Iloperidone (Fanapt): An FDA-approved treatment option for schizophrenia

Amy Barbara Montes; Jose A. Rey

Iloperidone (Fanapt): An FDA-approved treatment option for schizophrenia

Amy Barbara Montes
, Jose A. Rey

Research output: Contribution to journal › Short survey › peer-review

Original language	English
Pages (from-to)	606-608+612-613
Journal	P and T
Volume	34
Issue number	11
State	Published - Nov 2009

ASJC Scopus Subject Areas

Pharmacology (medical)

Keywords

Atypical antipsychotic agent
Fanapt
Iloperidone
Schizophrenia
Serotonin-dopamine receptor antagonist

Disciplines

Medical Pharmacology

Cite this

@article{7124a0c6530f470b8943b8b27cf4ca49,

title = "Iloperidone (Fanapt): An FDA-approved treatment option for schizophrenia",

keywords = "Atypical antipsychotic agent, Fanapt, Iloperidone, Schizophrenia, Serotonin-dopamine receptor antagonist",

author = "Montes, \{Amy Barbara\} and Rey, \{Jose A.\}",

year = "2009",

month = nov,

language = "English",

volume = "34",

pages = "606--608+612--613",

journal = "P and T",

issn = "1052-1372",

number = "11",

}

TY - JOUR

T1 - Iloperidone (Fanapt)

T2 - An FDA-approved treatment option for schizophrenia

AU - Montes, Amy Barbara

AU - Rey, Jose A.

PY - 2009/11

Y1 - 2009/11

KW - Atypical antipsychotic agent

KW - Fanapt

KW - Iloperidone

KW - Schizophrenia

KW - Serotonin-dopamine receptor antagonist

UR - https://www.scopus.com/pages/publications/73849126469

UR - https://www.scopus.com/pages/publications/73849126469#tab=citedBy

M3 - Short survey

AN - SCOPUS:73849126469

SN - 1052-1372

VL - 34

SP - 606-608+612-613

JO - P and T

JF - P and T

IS - 11

ER -

Iloperidone (Fanapt): An FDA-approved treatment option for schizophrenia

ASJC Scopus Subject Areas

Keywords

Disciplines

Other files and links

Cite this